Unique responses of limbic met-enkephalin systems to low and high doses of methamphetamine

Brain Research

Volumn 905, Issue 1-2, 2001, Pages 120-126

  Alburges, Mario E ^a   Keefe, Kristen A ^a   Hanson, Glen R ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Dopamine; Eticlopride; Frontal cortex; Met enkephalin; Methamphetamine; Nucleus accumbens; SCH 23390; Striatum

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; METENKEPHALIN; METHAMPHETAMINE;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE TIME EFFECT RELATION; DRUG EFFECT; FRONTAL CORTEX; LIMBIC SYSTEM; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; TISSUE LEVEL;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, METHIONINE; FRONTAL LOBE; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; MALE; METHAMPHETAMINE; NEOSTRIATUM; NEURAL PATHWAYS; NEURONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE;

EID: 0035968039     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02514-8     Document Type: Article

References (42)

1. Cocaine and methamphetamine differentially affect opioid peptide mRNA expression in the striatum
2. Contrasting responses by basal ganglia met-enkephalin systems to low and high doses of methamphetamine in a rat model
3. Involvement of dopamine D-1 and D-2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain
4. Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats
5. Medial forebrain bundle stimulation or D-2 dopamine receptor activation increases preproenkephalin mRNA in rat striatum
6. Chronic cocaine increases neurotensin gene expression in the shell of the nucleus accumbens and in discrete regions of the striatum
7. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
8. Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment
9. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
10. Evolving behavior in the clinical and experimental amphetamine (model) psychosis
11. Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway
12. Response of mesolimbic substance P systems to methamphetamine treatment
13. Responses of limbic extrapyramidal neurotensin systems to stimulants of abuse: Involvement of dopaminergic mechanisms
14. The accumbens: Beyond the core-shell dichotomy
15. Specificity in the projection patterns of accumbal core and shell in the rat
16. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists
17. +
18. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes
19. Functional and anatomical evidence for different dopamine dynamics in the core and shell of the nucleus accumbens in slices of rat brain
20. GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area
21. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell
22. Behavioral and neurochemical effects of cholinergic and dopaminergic agonists administered into the accumbal core and shell in rats
23. Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: Microdialysis combined with a sequential multiple antigen radioimmunoassay
24. CNS stimulants: Two distinct mechanisms of action for amphetamine-like drugs
25. Changes in the limbic neurotensin systems induced by dopaminergic drugs
26. The dopamine transporter: Comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens
27. A novel method for producing anti-peptide antibodies
28. Neuropharmacology of amphetamine: Changes in the activity of striatal neurons during behavior
29. Behavioral pharmacology of amphetamine
30. Role of N-methyl-D-aspartate receptors in D-1, but not D-2, mediated changes in striatal and accumbens neurotensin systems
31. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems
32. Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum
33. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior
34. Enkephalin regulates acute D-2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons
35. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system
36. Opioid receptor agonists selective for mu and kappa receptors attenuate methamphetamine-induced behavioral sensitization in the mouse
37. DAMGO ([D-Ala2,NMePhe4,Gly-ol]enkephalin), but not DPLPE ([D-Pen2,L-Pen5]enkephalin), specifically inhibits methamphetamine-induced behavioral responses in the mouse
38. Differential regulation of mu-opioid receptor mRNA in the nucleus accumbens shell and core accompanying amphetamine behavioral sensitization
39. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine and methamphetamine in rat forebrain
40. D-1 and D-2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine
41. Functional-anatomical implications of the nucleus accumbens core and shell subterritories